Understanding the mechanism of decreased expression could identify a potential means of reversing or reducing the chemoresistance, such as inhibition of the PI3K pathway in NSCLC cells with low HTRA1 expression. This evidence concerns the gene HTRA1 and non-small cell lung carcinoma.